Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133604-65-6

Post Buying Request

133604-65-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133604-65-6 Usage

Classification

Nonsteroidal anti-inflammatory drug (NSAID)
Belongs to the fenamate class of NSAIDs

Usage

Commonly used to treat pain and inflammation

Conditions treated

Rheumatoid arthritis, osteoarthritis

Mechanism of action

Inhibits the production of pain-causing chemicals
These chemicals include prostaglandins

Potency and duration

Relatively potent and long-acting

Tolerability

Generally well-tolerated by most patients

Side effects

Potential for gastrointestinal irritation, kidney effects, and increased cardiovascular risk

Precautions

Use as directed by a healthcare provider
Discuss potential risks and benefits with a qualified professional

Check Digit Verification of cas no

The CAS Registry Mumber 133604-65-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,6,0 and 4 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 133604-65:
(8*1)+(7*3)+(6*3)+(5*6)+(4*0)+(3*4)+(2*6)+(1*5)=106
106 % 10 = 6
So 133604-65-6 is a valid CAS Registry Number.

133604-65-6Relevant articles and documents

Relative Structure-Inhibition Analyses of the N-Benzoyl and N-(Phenylsulfonyl) Amino Acid Aldose Reductase Inhibitors

DeRuiter, Jack,Davis, R. Alan,Wandrekar, Vinay G.,Mayfield, Charles A.

, p. 2120 - 2126 (2007/10/02)

A number of N-benzoyl amino acids were synthesized and tested to compare structure-inhibition relationships with the isosteric N-(phenylsulfonyl) amino acid (PS-amino acid) aldose reductase inhibitors.Inhibition analyses with these series reveals that their kinetic mechanisms of inhibition are similar, but that significant differences in structure-inhibition relationships exist.For example, while the PS-alanines and PS-2-phenylglycines produce enantioselective inhibition (S > R), no consistent pattern of enantioselectivity is observed with the isosteric N-benzoylalanines and 2-phenylglycines.Also, N-methyl and N-phenyl substitution in the PS-amino acid series does not substantially alter inhibitory activity, while similar substitutions in the N-benzoyl series (particularly N-phenyl) results in a significant increase in inhibitory activity.Proton NMR analysis of the N-benzoylsarcosines reveals that these compounds exist as a mixture of rotamers in solutions including the enzyme assay buffer and that the preferred conformer is one in which the carboxymethyl moiety is trans to the aromatic ring.Similar analyses with the N-benzoyl-N-phenylglycines demonstrate that these derivatives exist exclusively in the trans rotameric conformation in solution.No such N-substituent effects on conformation were observed in the PS-amino acid series.These results suggest that the differences in structure-inhibition trends between these structurally related series may result from the effect of substituents on preferred conformation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133604-65-6